Table 1.
Same day | Early (1-7 days) | Delayed (8–14 days) | Late (> 14 days) | P-value* | |
---|---|---|---|---|---|
Total, No. (%) | 12 (10.9) | 27 (24.6) | 35 (31.8) | 36 (32.7) | |
Demographics | |||||
Gender, No. (%) | |||||
Women | 0 (0) | 5 (18.5) | 8 (22.6) | 8 (22.2) | |
Men | 12 (100) | 22 (81.5) | 27 (77.14) | 28 (77.8) | 0.336 |
Age, mean (SD) | 38.9 (14.8) | 44.2 (21.6) | 46.1 (19.6) | 47.0 (17.9) | 0.261 |
Lens status, No. (%) | |||||
Rupture | 8 (66.7) | 12 (44.4) | 10 (30.3) | 6 (26.1) | |
Aphakic | 0 (0) | 3 (11.1) | 5 (15.2) | 3 (13.0) | |
Pseudophakic | (0) | 1 (3.70) | 0 (0) | 1 (4.4) | 0.405 |
Injury type, No. (%) | |||||
Blunt | 1 (8.3) | 14 (51.9) | 23 (65.7) | 26 (72.2) | |
Sharp | 2 (16.7) | 7 (25.9) | 8 (22.9) | 8 (22.2) | |
IOFB | 9 (75.0) | 5 (18.5) | 2 (5.56) | 2 (5.56) | |
Projectile | 0 (0) | 1 (3.7) | 0 (0) | 0 (0) | < 0.001 |
Final VA, mean (SD) | 1.11 (0.98) | 1.40 (0.94) | 1.77 (1.0) | 1.97 (0.69) | < 0.05 |
Enucleation, No. (%) | 0 (0) | 2 (22.2) | 3 (33.3) | 4 (44.4) | 0.680 |
PVR, No. (%) | 0 (0) | 2 (8.0) | 10 (40.0) | 13 (52.0) | < 0.01 |
OTS, mean (SD)a | 2.45 (0.52) | 2.31 (0.89) | 1.72 (0.92) | 2.12 (0.88) | 0.589 |
Initial VA, No. (%) | 2.03 (0.76) | 1.99 (0.82) | 2.33 (0.54) | 2.29 (0.41) | 0.097 |
Endophthalmitis, No. (%) | 1 (20.0) | 2 (40.0) | 1(20.0) | 1 (20.0) | 0.707 |
OTS ocular trauma score, VA visual acuity, IOFB intraocular foreign body, PVR proliferative vitreoretinopathy, SD standard deviation, No., frequency
*P-values for χ2 test for categorical variables and ANOVA for continuous
aOTS score utilizes the variables initial vision, globe rupture, endophthalmitis, perforating injury, retinal detachment, and afferent pupillary defect (APD)